Drug Database
Back to search

Germany· DE-A57-7d456b22fa7ca3c4

Corotrop

A milrinone product containing milrinone, registered in Germany by Sanofi-Aventis Deutschland Gmbh. The same ATC class is registered in 16 of our 19 countries.

ATC C01CE02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCorotropATCC01CE02REGISTER NO.DE-A57-7d456b22fa7ca3…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about milrinoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Milrinone is registered in 16 of 19 countries.

Countries holding a registration under ATC C01CE02 (milrinone), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search milrinone products by name

Milrinone · ATC C01CE02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Milrinone
Manufacturer
Sanofi-Aventis Deutschland Gmbh
Country
Germany (DE)
ATC code
C01CE02
ATC class
Milrinone
Defined daily dose
50 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for milrinone.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check milrinone against other medicinesHow interaction checks work

Milrinone · interactions on record

5 records

  • 5 moderate

Most severe, free to view

  • ProcarbazineL01XB01moderate
  • AnagrelideL01XX35moderate
  • OzanimodL04AA38moderate
  • OzanimodL04AE02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Milrinone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All milrinone products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Asicor, Milrinon Carino
  • Belgium · Corotrope
  • Bulgaria · Milrinon Makpharm
  • Czechia · Asicord, Corotrop
  • Denmark · Milnocor, Milrinon Stragen
  • Spain · Corotrope, Milrinone
  • Finland · Milnocor, Milrinon Stragen
  • France · Corotrope, Milrinone Carinopharm
  • United Kingdom (Northern Ireland) · Milrinone Carinopharm, Milrinone Macure Pharma Uk
  • Greece · Corotrope
  • Croatia · Milrinon Makpharm
  • Hungary · Corotrope, Unacor
  • Ireland · Milrinone Pinewood Laboratories
  • Luxembourg · Corotrope
  • Malta · Milrinone Tillomed
  • Netherlands · Milrinon Carinopharm, Milrinon Devrimed
  • Norway · Milnocor, Milrinon Stragen
  • Poland · Asicor, Corotrope
  • Portugal · Corotrope
  • Romania · Milrinone Zentiva, Unacor
  • Sweden · Corotrop, Milrinon Carinopharm
  • Slovenia · Milrinon Makpharm
  • Slovakia · Asicord, Corotrope Inj

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cbc5bc13-5a5f-425b-809c-9fcedda62c09
GET /v1/drugs/cbc5bc13-5a5f-425b-809c-9fcedda62c09?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Milrinone",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about milrinone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console